LSA
BLFS icon

Leonteq Securities AG’s BioLife Solutions BLFS Stock Holding History

Leonteq Securities AG’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-41
Closed -$1.74K – 1261
2021
Q3 		$1.74K Buy
+41
New +$1.97K ﹤0.01% 1100
2021
Q2 		– Sell
-3,476
Closed -$125K – 1072
2021
Q1 		$125K Buy
+3,476
New +$137K 0.01% 630

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Leonteq Securities AG's BLFS Position: Q4 2021 in Review

Leonteq Securities AG sold out of BioLife Solutions (BLFS) in Q4 2021, closing a stake of 41 shares — an estimated $1.74K sold.

Leonteq Securities AG first reported a position in BLFS in Q1 2021 and held it in 2 quarters. The position peaked at $125K in Q1 2021. 169 funds tracked by Wall St. Rank hold BLFS as of Q4 2021.

  • Leonteq Securities AG reported no remaining BioLife Solutions position as of Q4 2021 after selling out during the quarter.
  • Leonteq Securities AG sold 41 BioLife Solutions shares in Q4 2021, an estimated $1.74K.
  • Leonteq Securities AG first reported a position in BioLife Solutions in Q1 2021 and held it in 2 quarters.
  • Leonteq Securities AG's BioLife Solutions position peaked at $125K in Q1 2021.
  • 169 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2021.

Based on Leonteq Securities AG's 13F filing for Q4 2021, filed 26 Mar 2026.